Theodore W.K. Ng - Search Results

Year	Number of Results
2005	3
2007	1
2009	2
2010	1
2011	2
2012	2
2013	2
2014	1
2015	2
2022	0

1

Genetic determinants of apolipoprotein B-100 kinetics.

Ng TW, Ooi EM, Watts GF, Chan DC, Barrett PH. Ng TW, et al. Curr Opin Lipidol. 2010 Apr;21(2):141-7. doi: 10.1097/MOL.0b013e3283378e5a. Curr Opin Lipidol. 2010. PMID: 20154610 Review.

2

Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis.

Chan DC, Ng TW, Watts GF. Chan DC, et al. Among authors: ng tw. Ann Med. 2012 Jun;44(4):313-24. doi: 10.3109/07853890.2011.573498. Epub 2011 Apr 18. Ann Med. 2012. PMID: 21501035 Review.

3

Dietary fatty acids and lipoprotein metabolism: new insights and updates.

Ooi EM, Ng TW, Watts GF, Barrett PH. Ooi EM, et al. Among authors: ng tw. Curr Opin Lipidol. 2013 Jun;24(3):192-7. doi: 10.1097/MOL.0b013e3283613ba2. Curr Opin Lipidol. 2013. PMID: 23619368 Review.

4

Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update.

Ooi EM, Watts GF, Ng TW, Barrett PH. Ooi EM, et al. Among authors: ng tw. Nutrients. 2015 Jun 2;7(6):4416-25. doi: 10.3390/nu7064416. Nutrients. 2015. PMID: 26043038 Free PMC article. Review.

5

Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome.

Ng TW, Ooi EM, Watts GF, Chan DC, Weir JM, Meikle PJ, Barrett PH. Ng TW, et al. J Clin Endocrinol Metab. 2014 Nov;99(11):E2335-40. doi: 10.1210/jc.2014-1665. Epub 2014 Aug 20. J Clin Endocrinol Metab. 2014. PMID: 25140396 Free article. Clinical Trial.

6

Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome.

Ooi EM, Ng TW, Watts GF, Chan DC, Barrett PH. Ooi EM, et al. Among authors: ng tw. J Lipid Res. 2012 Nov;53(11):2443-9. doi: 10.1194/jlr.P029223. Epub 2012 Aug 28. J Lipid Res. 2012. PMID: 22930812 Free PMC article. Clinical Trial.

7

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.

Ooi EM, Chan DT, Watts GF, Chan DC, Ng TW, Dogra GK, Irish AB, Barrett PH. Ooi EM, et al. Among authors: ng tw. J Lipid Res. 2011 Apr;52(4):794-800. doi: 10.1194/jlr.M011163. Epub 2011 Feb 6. J Lipid Res. 2011. PMID: 21297177 Free PMC article.

8

Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.

Wong AT, Chan DC, Ooi EM, Ng TW, Watts GF, Barrett PH. Wong AT, et al. Among authors: ng tw. Clin Sci (Lond). 2013 Mar 13;125(1):45-51. doi: 10.1042/CS20120587. Clin Sci (Lond). 2013. PMID: 23356247

9

Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment.

Ng TW, Ooi EM, Watts GF, Chan DC, Meikle PJ, Barrett PH. Ng TW, et al. J Clin Endocrinol Metab. 2015 Jun;100(6):2497-501. doi: 10.1210/jc.2014-4348. Epub 2015 Mar 27. J Clin Endocrinol Metab. 2015. PMID: 25816050 Clinical Trial.

10

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

Ng TW, Chan DC, Barrett PH, Watts GF. Ng TW, et al. Clin Sci (Lond). 2009 Oct 2;118(1):79-85. doi: 10.1042/CS20090110. Clin Sci (Lond). 2009. PMID: 19456294 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results